• Publications
  • Influence
2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.
Reduction in febrile neutropenia (FN) is an important clinical outcome that justifies the use of CSFs, regardless of impact on other factors, when the risk of FN is approximately 20% and no other equally effective regimen that does not require CSFs is available. Expand
American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care.
It is the Panel's expert consensus that combined standard oncology care and palliative care should be considered early in the course of illness for any patient with metastatic cancer and/or high symptom burden. Expand
Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update.
Current recommendations for the management of patients exposed to lethal doses of total-body radiotherapy, but not doses high enough to lead to certain death as a result of injury to other organs, include the prompt administration of CSFs. Expand
American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.
The American Society of Clinical Oncology (ASCO) previously published evidencebased guidelines for the treatment of unresectable non–small-cell lung cancer (NSCLC) [1]. ASCO guidelines are updatedExpand
American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer.
The scope of the guideline was narrowed to chemotherapy and biologic therapy, and recommendations for the treatment of patients with stage IV non-small-cell lung cancer were updated. Expand
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options.
The high costs associated with cancer care have created a difficult situation for patients and the oncologists who care for them and will require greater understanding of all the risks and benefits of various treatment options as well as the consequences of specific choices. Expand
American society of clinical oncology statement: toward individualized care for patients with advanced cancer.
The goals for individualized care, barriers that currently limit realization of this vision, and possible strategies to overcome these barriers that can improve care consistent with the goals of patients and evidence-based medical practice are outlined. Expand
Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update.
The Update Committee concluded that no revisions to the existing ASCO recommendations were warranted and recommended regular history, physical examination, and mammography for breast cancer follow-up. Expand
Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update.
The guideline update reflects changes in evidence since the previous guideline and inpatients and outpatients with advanced cancer should receive dedicated palliative care services, early in the disease course, concurrent with active treatment. Expand
American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting.
Careful history taking, physical examination, and regular mammography are recommended for appropriate detection of breast cancer recurrence. Expand